Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lisa Menegazzo

Showing results (11-20 of 25) with videos related to

Pageof 3
Sort By:
The Journal of Clinical Endocrinology and Metabolism|December 24, 2015
Acute Effects of Linagliptin on Progenitor Cells, Monocyte Phenotypes, and Soluble Mediators in Type 2 DiabetesGian Paolo Fadini, Benedetta Maria Bonora, Roberta Cappellari, et al.
Diabetes|April 30, 2020
Pharmacologic PPAR-γ Activation Reprograms Bone Marrow Macrophages and Partially Rescues HSPC Mobilization in Human and Murine DiabetesSerena Tedesco, Stefano Ciciliot, Lisa Menegazzo, et al.
Diabetes|March 26, 2015
Bone Marrow Macrophages Contribute to Diabetic Stem Cell Mobilopathy by Producing Oncostatin MMattia Albiero, Nicol Poncina, Stefano Ciciliot, et al.
Vascular Pharmacology|December 9, 2014
Short-term statin discontinuation increases endothelial progenitor cells without inflammatory rebound in type 2 diabetic patientsGian Paolo Fadini, Mauro Rigato, Federico Boscari, et al.
Acta Diabetologica|November 13, 2014
NETosis is induced by high glucose and associated with type 2 diabetesLisa Menegazzo, Stefano Ciciliot, Nicol Poncina, et al.
Diabetes|March 26, 2015
Diabetes Limits Stem Cell Mobilization Following G-CSF but Not PlerixaforGian Paolo Fadini, Mark Fiala, Roberta Cappellari, et al.
Acta Diabetologica|March 17, 2018
The antidiabetic drug metformin blunts NETosis in vitro and reduces circulating NETosis biomarkers in vivoLisa Menegazzo, Valentina Scattolini, Roberta Cappellari, et al.
Diabetes|November 26, 2013
Diabetes causes bone marrow autonomic neuropathy and impairs stem cell mobilization via dysregulated p66Shc and Sirt1Mattia Albiero, Nicol Poncina, Marc Tjwa, et al.
Diabetes|April 3, 2019
Diabetes-Associated Myelopoiesis Drives Stem Cell Mobilopathy Through an OSM-p66Shc Signaling PathwayMattia Albiero, Stefano Ciciliot, Serena Tedesco, et al.
Basic Research in Cardiology|November 28, 2012
Stem cell compartmentalization in diabetes and high cardiovascular risk reveals the role of DPP-4 in diabetic stem cell mobilopathyGian Paolo Fadini, Mattia Albiero, Florian Seeger, et al.
Pageof 3

Showing results (11-20 of 25) with videos related to

Sort By:
Pageof 3
The Journal of Clinical Endocrinology and Metabolism|December 24, 2015
Acute Effects of Linagliptin on Progenitor Cells, Monocyte Phenotypes, and Soluble Mediators in Type 2 DiabetesGian Paolo Fadini, Benedetta Maria Bonora, Roberta Cappellari, et al.
Diabetes|April 30, 2020
Pharmacologic PPAR-γ Activation Reprograms Bone Marrow Macrophages and Partially Rescues HSPC Mobilization in Human and Murine DiabetesSerena Tedesco, Stefano Ciciliot, Lisa Menegazzo, et al.
Diabetes|March 26, 2015
Bone Marrow Macrophages Contribute to Diabetic Stem Cell Mobilopathy by Producing Oncostatin MMattia Albiero, Nicol Poncina, Stefano Ciciliot, et al.
Vascular Pharmacology|December 9, 2014
Short-term statin discontinuation increases endothelial progenitor cells without inflammatory rebound in type 2 diabetic patientsGian Paolo Fadini, Mauro Rigato, Federico Boscari, et al.
Acta Diabetologica|November 13, 2014
NETosis is induced by high glucose and associated with type 2 diabetesLisa Menegazzo, Stefano Ciciliot, Nicol Poncina, et al.
Diabetes|March 26, 2015
Diabetes Limits Stem Cell Mobilization Following G-CSF but Not PlerixaforGian Paolo Fadini, Mark Fiala, Roberta Cappellari, et al.
Acta Diabetologica|March 17, 2018
The antidiabetic drug metformin blunts NETosis in vitro and reduces circulating NETosis biomarkers in vivoLisa Menegazzo, Valentina Scattolini, Roberta Cappellari, et al.
Diabetes|November 26, 2013
Diabetes causes bone marrow autonomic neuropathy and impairs stem cell mobilization via dysregulated p66Shc and Sirt1Mattia Albiero, Nicol Poncina, Marc Tjwa, et al.
Diabetes|April 3, 2019
Diabetes-Associated Myelopoiesis Drives Stem Cell Mobilopathy Through an OSM-p66Shc Signaling PathwayMattia Albiero, Stefano Ciciliot, Serena Tedesco, et al.
Basic Research in Cardiology|November 28, 2012
Stem cell compartmentalization in diabetes and high cardiovascular risk reveals the role of DPP-4 in diabetic stem cell mobilopathyGian Paolo Fadini, Mattia Albiero, Florian Seeger, et al.
Pageof 3